合成磁共振成像定量评估前列腺癌骨转移
这项前瞻性研究纳入96例前列腺癌患者,在分期或开始新一线抗癌治疗时行全身MRI(含扩散加权成像)并加做腰骶椎、骨盆及股骨近端的合成MRI。结果显示,质子密度(PD)值可独立鉴别活动性(存活)骨转移灶与无活性(非存活)骨转移灶,PD值诊断活动性疾病的曲线下面积(AUC)为reader 1 0.93、reader 2 0.92。
要点
- PD值可独立鉴别前列腺癌活动性骨转移灶(P<0.001)。
- PD值诊断活动性疾病的AUC:reader 1 0.93、reader 2 0.92,优于T1(0.81/0.78)和T2(0.69/0.70)。
- 活动性骨转移灶PD值显著高于无硬化无活性灶及红骨髓(P<0.001)。
核心结论
- 合成MRI信号定量可对下躯干骨病变进行客观评估,PD值可能有助于判断前列腺癌骨转移灶的活性。
研究设计与样本
- 机构审查委员会批准的前瞻性研究,纳入96例连续前列腺癌患者,在诊断分期或开始新一线抗癌治疗时行全身MRI(含扩散加权成像),并加做腰骶椎、骨盆及股骨近端的合成MRI;由2名独立且对骨病变诊断不知情的读片者,在每个骨病变处放置直径1.0 cm的感兴趣区。
诊断标准与关键数值
- 共93个骨病变纳入分析;活动性(存活)骨转移灶PD值显著高于无硬化无活性骨转移灶及红骨髓(两名读片者P均<0.001);伴硬化无活性骨转移灶PD值显著低于无硬化无活性骨转移灶及红骨髓(两名读片者P均<0.001);PD值为鉴别骨病变的独立显著指标(P<0.001);T1/T2/PD诊断活动性疾病的AUC分别为reader 1 0.81/0.69/0.93、reader 2 0.78/0.70/0.92。
临床应用与阅片要点
- 作者认为,合成MRI信号定量可对下躯干骨病变进行客观评估,PD值可能有助于判断前列腺癌骨转移灶的活性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aims of this study were to evaluate the feasibility of quantitative synthetic magnetic resonance imaging (SyMRI) for characterizing bone lesions in prostate cancer and to discriminate viable progressive osteoblastic bone metastasis from nonviable bone metastases with treatment-induced sclerosis during the treatment course.
MATERIALS AND METHODS: This institutional review board-approved prospective study included 96 consecutive prostate cancer patients who underwent whole-body MRI including diffusion-weighted imaging at the time of staging at diagnosis or starting a new line of anticancer treatment. Additional synthetic MRI of the lumbosacral spine, pelvis, and proximal femurs was performed. A region of interest of 1.0 cm in diameter was set in each bone lesion by 2 independent readers who were blinded to bone lesions' diagnosis. Differences in SyMRI variables between the different bone lesions were compared with the Wilcoxon rank sum test, and associations of SyMRI variables with active disease were analyzed with logistic regression analysis. Performance of T1, T2, and proton density (PD) for diagnosing active disease was assessed using the area under the receiver operating characteristic curve.
RESULTS: Ninety-three bone lesions were eligible for analysis. The PD values of active (viable) bone metastatic lesions were significantly higher than those of inactive (nonviable) bone metastatic lesions without sclerosis and those of red bone marrow (P < 0.001 for both readers). The PD values of inactive bone metastatic lesions with sclerosis were significantly lower than those of inactive bone metastatic lesions without sclerosis and red bone marrow (P < 0.001 for both readers). The PD value proved to be an independent significant indicator (P < 0.001) for differentiating bone lesions. The areas under the curve of T1/T2/PD for identifying active disease were 0.81/0.69/0.93 for reader 1 and 0.78/0.70/0.92 for reader 2, respectively.
CONCLUSIONS: Signal quantification on SyMRI provides objective assessment of bone lesions in the lower trunk. The PD value can be useful to determine the viability of bone metastases in prostate cancer.
引用
- Arita Y, Takahara T, Yoshida S, et al. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019. PMID: 31192827. doi:10.1097/RLI.0000000000000579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。